chr4-83331997-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001098540.3(HPSE):c.227+2559G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.839 in 152,200 control chromosomes in the GnomAD database, including 54,312 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.84 ( 54312 hom., cov: 32)
Consequence
HPSE
NM_001098540.3 intron
NM_001098540.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.169
Publications
5 publications found
Genes affected
HPSE (HGNC:5164): (heparanase) Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.965 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HPSE | NM_001098540.3 | c.227+2559G>A | intron_variant | Intron 1 of 11 | ENST00000311412.10 | NP_001092010.1 | ||
| HPSE | NM_006665.6 | c.227+2559G>A | intron_variant | Intron 2 of 12 | NP_006656.2 | |||
| HPSE | NM_001199830.1 | c.227+2559G>A | intron_variant | Intron 1 of 10 | NP_001186759.1 | |||
| HPSE | NM_001166498.3 | c.227+2559G>A | intron_variant | Intron 2 of 10 | NP_001159970.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.840 AC: 127691AN: 152082Hom.: 54303 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
127691
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.839 AC: 127730AN: 152200Hom.: 54312 Cov.: 32 AF XY: 0.839 AC XY: 62427AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
127730
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
62427
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
28453
AN:
41474
American (AMR)
AF:
AC:
13574
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
3132
AN:
3472
East Asian (EAS)
AF:
AC:
5123
AN:
5190
South Asian (SAS)
AF:
AC:
4203
AN:
4828
European-Finnish (FIN)
AF:
AC:
9206
AN:
10598
Middle Eastern (MID)
AF:
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
AC:
61140
AN:
68024
Other (OTH)
AF:
AC:
1828
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
989
1977
2966
3954
4943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3182
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.